These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22082200)

  • 1. Sustained-release oxycodone tablets for moderate to severe painful diabetic peripheral neuropathy: a multicenter, open-labeled, postmarketing clinical observation.
    Yao P; Meng LX; Ma JM; Ding YY; Wang ZB; Zhao GL; Tao R; Wu YX; Wang QS; Zhang Z; Zhao YD; Zhang SW; Liu JF; Guo HJ; Xu G; Wu BS
    Pain Med; 2012 Jan; 13(1):107-14. PubMed ID: 22082200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients.
    Hanna M; O'Brien C; Wilson MC
    Eur J Pain; 2008 Aug; 12(6):804-13. PubMed ID: 18262450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain.
    Yu SY;
    Oncology; 2008; 74 Suppl 1():46-51. PubMed ID: 18758197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe postherpetic neuralgia pain.
    Fan BF;
    Oncology; 2008; 74 Suppl 1():66-71. PubMed ID: 18758201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlled-release oxycodone--a therapeutic option for severe neuropathic pain. Two multicenter observational studies].
    Wörz R; Frank M; Achenbach U
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():71-6. PubMed ID: 15490770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
    Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
    Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets.
    Koizumi W; Toma H; Watanabe K; Katayama K; Kawahara M; Matsui K; Takiuchi H; Yoshino K; Araki N; Kodama K; Kimura H; Kono I; Hasegawa H; Hatanaka K; Hiraga K; Takeda F
    Jpn J Clin Oncol; 2004 Oct; 34(10):608-14. PubMed ID: 15591459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.
    Portenoy RK; Farrar JT; Backonja MM; Cleeland CS; Yang K; Friedman M; Colucci SV; Richards P
    Clin J Pain; 2007 May; 23(4):287-99. PubMed ID: 17449988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy.
    Freeman R; Raskin P; Hewitt DJ; Vorsanger GJ; Jordan DM; Xiang J; Rosenthal NR;
    Curr Med Res Opin; 2007 Jan; 23(1):147-61. PubMed ID: 17257476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
    Nicholson B; Ross E; Sasaki J; Weil A
    Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study to demonstrate noninferiority of once-daily OROS(®) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain.
    Binsfeld H; Szczepanski L; Waechter S; Richarz U; Sabatowski R
    Pain Pract; 2010; 10(5):404-15. PubMed ID: 20384968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain.
    Pan H; Zhang Z; Zhang Y; Xu N; Lu L; Dou C; Guo Y; Wu S; Yue J; Wu D; Dai Y
    Clin Drug Investig; 2007; 27(4):259-67. PubMed ID: 17358098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
    Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
    Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of oxycodone controlled-release immediately after NSAIDs: a new approach to obtain good pain control.
    Tessaro L; Bandieri E; Costa G; Fornasier G; Iorno V; Pizza C; Pastacaldi G; Micheletto G
    Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):113-21. PubMed ID: 20329570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial.
    Gimbel JS; Richards P; Portenoy RK
    Neurology; 2003 Mar; 60(6):927-34. PubMed ID: 12654955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.